Figure 3

Effects of the PPARδ-agonist on adipose tissue renin and Ang II levels, and on the marker of oxidative stress; results are means±s.e., n=6/group. (a) Adipose tissue renin; *P<0.05 vs control, #P<0.05 vs 2K1C,+P<0.05 vs 2K1C+GW. (b) Adipose tissue Ang II; *P<0.05 vs control, #P<0.05 vs 2K1C,+P<0.05 vs 2K1C+GW. (c) Western blot and densitometry analysis of gp phox 91expression; *P<0.05 vs control, #P<0.05 vs 2K1C,+P<0.05 vs 2K1C+GW. Data are shown as mean band density normalized to β-actin.